Richard T. Silver MD Myeloproliferative Neoplasms Center

You are here

Dr. Richard Silver Recognized for Excellence in Hematology

Dr. Richard T. Silver, Emeritus Director of the Richard T. Silver Myeloproliferative Neoplasms (MPN) Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital, was recently honored for his tremendous contributions to the field of hematology with the 2019 Celgene Career Achievement Award for Clinical Research in Hematology.

... Read More...

Dr. Richard Silver Recognized for Excellence in Hematology

Dr. Silver received the 2019 Celgene Career Achievement Award for Clinical Research in Hematology.

Dr. Richard T. Silver, Emeritus Director of the Richard T. Silver Myeloproliferative Neoplasms (MPN) Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital, was recently honored for his tremendous contributions to the field of hematology with the 2019 Celgene Career Achievement Award for Clinical Research in Hematology.

2017 American Society of Hematology Annual Meeting and Exposition

Scientists and physicians from the Silver MPN Center made a splash at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, an educational gathering of over 25,000 healthcare professionals from around the world who are working to conquer blood disease. Here are some research highlights from the meeting:

9th International Patient Symposium on Myeloproliferative Neoplasms

On November 1st, Weill Cornell Medicine and the Cancer Research & Treatment (CR&T) Fund hosted a full-day educational event for over 200 patients and their families to learn about the latest developments in the research and treatment of myeloproliferative neoplasms (MPNs).

Weill Cornell Medicine Team Creates Self-Renewing Hematopoietic Stem Cells for Transplantation

Weill Cornell Medicine stem cell team

Hematopoietic stem cells (HSCs) are long-lasting cells that mature into all types of blood cells: white blood cells, red blood cells and platelets. Almost a trillion new blood cells must be replaced each day to replace normal loss of old blood cells. “Bone Marrow Transplant” is a procedure currently used by clinicians to transplant HSCs and cure a wide range of blood diseases. But not all patients have a suitable donor for a HSC transplant. For the first-time ever, Dr.

The MPN Interferon Initiative

Dr. Joseph Scandura selected as one of four investigators for a new, multi-institution project launching in 2018: The MPN Interferon Initiative. This research project aims to evaluate how targeting the interferon pathway can be used to treat MPN patients and why this is effectively in only a subset of patients.

Visiting Professor Dr. Richard Stone Teaches Hematology & Oncology Fellows

Visiting Professor Dr. Richard Stone Teaches Hematology & Oncology Fellows

Dr. Richard Stone, Professor of Medicine at Harvard University Medical College visits Weill Cornell Medical College. Dr. Stone is pictured here teaching Hematology and Medical Oncology Fellows. 

Dr. Ellen Ritchie Reflects on Research Underway in Myeloproliferative Neoplasms

Dr. Ritchie speaks at the OncLive Summit.

Researchers are examining a variety of therapeutic regimens for patients with myeloproliferative neoplasms (MPNs), as well as working to obtain a deeper understanding of the biology of these conditions. This includes investigating combining new biologic agents with FDA-approved therapies in order to improve response rates and quality of life (QOL). Dr.

CR&T Visits Silver MPN Center Lab

CR&T Visits Silver MPN Center Lab.

The Cancer Research and Treatment Fund (CR&T) Board Members visit the research laboratory of Dr. Joseph Scandura, Scientific Director of the Silver MPN Center.

2016 MPN Congress

Speakers at the 2016 MPN Congress.

The 2016 MPN Congress, “Myeloproliferative Neoplasms for the Practitioner: Diagnosis, Management and New Clinical Developments” was held on November 3-5, 2016 in Brooklyn, New York.

Dr. Joseph Scandura Appointed Silver MPN Center Scientific Director

Dr. Joseph Scandura

Joseph Scandura, M.D., Ph.D., has been named Scientific Director of the Richard T. Silver, M.D. Myeloproliferative Neoplasms Center at Weill Cornell Medicine. In this newly created position, Dr. Scandura will oversee clinical and basic research targeting myeloproliferative neoplasms (MPNs), a group of diseases causing excessive production of certain blood cells by the bone marrow. 

Richard T. Silver MD Myeloproliferative Neoplasms Center 525 East 70th St., Starr Pavillion, 3rd Floor New York, NY 10021 SilverMPNCenter@med.cornell.edu